top of page

Batten Disease

Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement

Cannabidiol reduces host immune response and prevents cognitive impairments in Wistar rats submitted to pneumococcal meningitis.

Cannabidiol reduces lipopolysaccharide-induced vascular changes and inflammation in the mouse brain: an intravital microscopy study.

Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins.

siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration.

Breast Cancer

Antitumor activity of plant cannabinoids with emphasis on the effect of Cannabidiol on Human Breast Carcinoma.

Cannabidiol as a novel inhibitor of Id-1 gene expression in aggressive breast cancer cells.

Cannabidiol induces programmed cell death in breast cancer cells by coordinating the cross-talk between apoptosis and autophagy.

Cannabinoids: a new hope for breast cancer therapy.

Cannabinoids reduce ErbB2-driven breast cancer progression through Akt inhibition.

Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent.

Pathways mediating the effects of cannabidiol on the reduction of breast cancer cell proliferation, invasion, and metastasis.

Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer.

Targeting multiple cannabinoid anti-tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer.

The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation.

bottom of page